We are live on
!
Find out more
CM
Caption Management Portfolio holdings
AUM
$17.1B
1-Year Est. Return
70.99%
This Fund
S&P 500
This Quarter
Est. Return
+4.28%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
–
AUM
$1.99B
AUM Growth
+$172M
(+9.5%)
Cap. Flow
+$156M
Cap. Flow
% of AUM
7.83%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
935
New
395
Increased
92
Reduced
99
Closed
294
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$8.42M |
| 2 |
Marathon Petroleum
MPC
|
+$5.47M |
| 3 |
Liberty Global Class C
LBTYK
|
+$5.39M |
| 4 |
O'Reilly Automotive
ORLY
|
+$5.32M |
| 5 |
Crocs
CROX
|
+$5.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.6M |
| 2 |
Tapestry
TPR
|
+$12M |
| 3 |
iShares MSCI Saudi Arabia ETF
KSA
|
+$8.32M |
| 4 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$6.96M |
| 5 |
SAGE
Sage Therapeutics
SAGE
|
+$6.93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.95% |
| 2 | Consumer Discretionary | 2.51% |
| 3 | Technology | 1.96% |
| 4 | Energy | 1.43% |
| 5 | Communication Services | 1.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APC
1
PUT
DELISTED
Anadarko Petroleum
APC
| $48.5M | 2.44% |
+686,900
| New | +$46M |
|
2
PUT
Amgen
AMGN
$208B
| $48.2M | 2.42% |
+261,300
| New | +$46.8M |
|
3
CALL
uniQure
QURE
$3.03B
| $47M | 2.36% |
600,800
+580,800
| +2,904% | +$37M |
|
4
PUT
DaVita
DVA
$15.4B
| $30.1M | 1.52% |
+535,800
| New | +$27.8M |
|
|
MDCO
5
PUT
DELISTED
Medicines Co
MDCO
| $28.5M | 1.43% |
781,300
+286,400
| +58% | +$9.35M |
|
6
PUT
Centene
CNC
$30.7B
| $27M | 1.36% |
514,000
+294,000
| +134% | +$15.9M |
|
|
MRTX
7
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $26.5M | 1.33% |
257,200
+257,100
| +257,100% | +$20M |
|
|
MDCO
8
CALL
DELISTED
Medicines Co
MDCO
| $23.9M | 1.2% |
654,200
+299,700
| +85% | +$9.78M |
|
|
WCG
9
CALL
DELISTED
Wellcare Health Plans, Inc.
WCG
| $22M | 1.11% |
+77,200
| New | +$21.3M |
|
10
PUT
Targa Resources
TRGP
$58B
| $21.7M | 1.09% |
552,100
| – | – |
|
11
PUT
Beyond Meat
BYND
$292M
| $20.9M | 1.05% |
+130,000
| New | +$14.5M |
|
12
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$790B
| $20.5M | 1.03% |
+70,000
| New | +$20.2M |
|
|
BHVN
13
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $17.2M | 0.86% |
+391,800
| New | +$22.1M |
|
14
CALL
Union Pacific
UNP
$174B
| $16.9M | 0.85% |
100,000
| – | – |
|
|
15
CALL
Marathon Petroleum
MPC
$92.4B
| $16.8M | 0.84% |
+300,000
| New | +$16.4M |
|
|
EE
16
CALL
DELISTED
El Paso Electric Company
EE
| $16.4M | 0.82% |
+250,400
| New | +$15.4M |
|
17
CALL
Tractor Supply
TSCO
$16.1B
| $16.3M | 0.82% |
+750,000
| New | +$15.5M |
|
18
PUT
Edison International
EIX
$28.2B
| $16.3M | 0.82% |
242,000
+57,000
| +31% | +$3.54M |
|
19
CALL
Ferrari
RACE
$69.2B
| $16.3M | 0.82% |
+100,700
| New | +$14.5M |
|
|
EXAS
20
PUT
DELISTED
Exact Sciences
EXAS
| $15.8M | 0.8% |
133,800
-25,000
| -16% | -$2.52M |
|
21
CALL
PG&E
PCG
$38.3B
| $15.5M | 0.78% |
677,300
+137,300
| +25% | +$2.76M |
|
22
CALL
Liberty Global Class A
LBTYA
$3.62B
| $15.4M | 0.78% |
+570,400
| New | +$15M |
|
|
23
PUT
Tapestry
TPR
$30.8B
| $14.2M | 0.71% |
446,500
-417,500
| -48% | -$13M |
|
|
PLAN
24
CALL
DELISTED
Anaplan, Inc.
PLAN
| $14M | 0.71% |
+278,100
| New | +$11.5M |
|
|
AABA
25
PUT
DELISTED
Altaba Inc
AABA
| $13.8M | 0.7% |
+199,500
| New | +$14M |
|
Similar funds
ASRS
PP
VMPIC
BCIM
BBA
FCM
AIMCA
Caption Management's Q2 2019 Portfolio in Review
As of Q2 2019, Caption Management held 935 positions worth $1.99B, up 9.5% from $1.81B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Caption Management deployed $156M of net new capital in Q2 2019, opening 395 new positions and adding to 92 existing holdings. Its largest new stake was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
By sector, the portfolio is most concentrated in Healthcare at 3% of assets, down from 3.9% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $12.6M trimmed.
- Caption Management's largest Q2 2019 buy was Spark Therapeutics, Inc. Common Stock: 78,000 shares worth $7.99M.
- Caption Management added most to Crocs in Q2 2019, an estimated $5.07M increase.
- Caption Management's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $12.6M.
- Caption Management fully exited iShares MSCI Saudi Arabia ETF in Q2 2019, selling an estimated $8.32M.
- Caption Management's ten largest holdings make up 16% of its $1.99B portfolio in Q2 2019.
- Caption Management opened 395 new positions and closed 294 in Q2 2019.
- Caption Management's portfolio value rose 9.5% quarter-over-quarter to $1.99B.
Based on Caption Management's 13F filing for Q2 2019, filed 13 Aug 2019.